{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:28:31Z","timestamp":1791581311410,"version":"4.3.4"},"reference-count":71,"publisher":"Centers for Disease Control MMWR Office","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Surveill. Summ."],"DOI":"10.15585\/mmwr.ss6808a1","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T16:10:28Z","timestamp":1569514228000},"page":"1-15","source":"Crossref","is-referenced-by-count":183,"title":["Population-Based Active Surveillance for Culture-Confirmed Candidemia \u2014 Four Sites, United States, 2012\u20132016"],"prefix":"10.15585","volume":"68","author":[{"given":"Mitsuru","family":"Toda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Berkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaytlynn M.","family":"Marceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Hollick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn R.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snigdha","family":"Vallabhaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem.","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2015.10.004","article-title":"The global burden of fungal diseases.","volume":"30","author":"Vallabhaneni","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R3","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals.","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R5","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014.","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R6","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011.","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R7","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1086\/323759","article-title":"Revisiting the source of candidemia: skin or gut?","volume":"33","author":"Nucci","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.arcmed.2005.05.015","article-title":"Invasive candidiasis in immunocompromised hospitalized patients.","volume":"36","author":"Sims","year":"2005","journal-title":"Arch Med Res"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R9","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","article-title":"Risk factors for hospital-acquired candidemia. A matched case-control study.","volume":"149","author":"Wey","year":"1989","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis.","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R11","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1097\/INF.0b013e3182863a1c","article-title":"Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.","volume":"32","author":"Pammi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpeds.2005.02.021","article-title":"Risk factors for candidemia in critically ill infants: a matched case-control study.","volume":"147","author":"Feja","year":"2005","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R13","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis.","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital.","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1086\/510677","article-title":"Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.","volume":"44","author":"Segal","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R16","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants.","volume":"345","author":"Kaufman","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R17","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.","volume":"50","author":"Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1213\/ane.0b013e3181607262","article-title":"Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.","volume":"106","author":"Dimopoulos","year":"2008","journal-title":"Anesth Analg"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R19","doi-asserted-by":"crossref","first-page":"ofv163","DOI":"10.1093\/ofid\/ofv163","article-title":"Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008\u20132014.","volume":"2","author":"Vallabhaneni","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R20","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel Ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol Immunol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R22","unstructured":"CDC. TrackingCandida auris[Internet]. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/fungal\/diseases\/candidiasis\/tracking-c-auris.html"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R23","doi-asserted-by":"publisher","first-page":"86S","DOI":"10.1016\/0002-9343(91)90349-3","article-title":"Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989.","volume":"91","author":"Banerjee","year":"1991","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R24","doi-asserted-by":"publisher","first-page":"116S","DOI":"10.1016\/0002-9343(91)90355-2","article-title":"The national nosocomial infections surveillance system: plans for the 1990s and beyond.","volume":"91","author":"Gaynes","year":"1991","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R25","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1542\/peds.2005-1996","article-title":"Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995\u20132004.","volume":"117","author":"Fridkin","year":"2006","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R26","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1093\/jpids\/piy009","article-title":"Neonatal and pediatric candidemia: results from population-based active laboratory surveillance in four U.S. locations, 2009\u20132015.","volume":"7","author":"Benedict","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/cid\/cit679","article-title":"Decreasing rates of invasive candidiasis in pediatric hospitals across the United States.","volume":"58","author":"Fisher","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R28","doi-asserted-by":"publisher","first-page":"e0120452","DOI":"10.1371\/journal.pone.0120452","article-title":"Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two U.S. metropolitan areas, 2008\u20132013: results from population-based surveillance.","volume":"10","author":"Cleveland","year":"2015","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R29","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1086\/313450","article-title":"The epidemiology of candidemia in two United States cities: results of a population-based active surveillance.","volume":"29","author":"Kao","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R30","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R31","unstructured":"CDC.Candida auris.2019 case definition [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/wwwn.cdc.gov\/nndss\/conditions\/candida-auris\/case-definition\/2019"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R32","unstructured":"CDC. Emerging Infections Program [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/ncezid\/dpei\/eip\/index.html"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1139\/W10-003","article-title":"Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance.","volume":"56","author":"Deak","year":"2010","journal-title":"Can J Microbiol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R34","doi-asserted-by":"publisher","first-page":"1193A","DOI":"10.1021\/ac00024a716","article-title":"Matrix-assisted laser desorption\/ionization mass spectrometry of biopolymers.","volume":"63","author":"Hillenkamp","year":"1991","journal-title":"Anal Chem"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R35","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard\u2014third edition [Internet]. CLSI document no. M27\u2013A3. Vol. 27, No. 9. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. https:\/\/clsi.org\/media\/1461\/m27a3_sample.pdf"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R36","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R37","unstructured":"US Census Bureau. Population and housing unit estimates data. Washington, DC: US Census Bureau; 2018. https:\/\/www.census.gov\/programs-surveys\/popest\/data.html"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3201\/eid2403.170623","article-title":"Coccidioidomycosis outbreaks, United States and worldwide, 1940\u20132015.","volume":"24","author":"Freedman","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3201\/eid2403.171258","article-title":"Multistate epidemiology of histoplasmosis, United States, 2011\u20132014.","volume":"24","author":"Armstrong","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R40","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.2018.0158","article-title":"The state of U.S. health, 1990\u20132016: burden of diseases, injuries, and risk factors among U.S. states.","volume":"319","author":"Mokdad","year":"2018","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R41","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1371\/journal.pmed.0030260","article-title":"Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States.","volume":"3","author":"Murray","year":"2006","journal-title":"PLoS Med"},{"issue":"No. RR-6","key":"key-10.15585\/mmwr.ss6808a1-201909261208-R42","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship.","volume":"65","author":"Sanchez","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R43","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jamainternmed.2014.5486","article-title":"Effect of Medicare\u2019s nonpayment for hospital-acquired conditions: lessons for future policy.","volume":"175","author":"Waters","year":"2015","journal-title":"JAMA Intern Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R45","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis.","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/IAI.46.2.346-353.1984","article-title":"Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis.","volume":"46","author":"Restrepo","year":"1984","journal-title":"Infect Immun"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1128\/IAI.56.3.711-713.1988","article-title":"Inhibition by estrogens of conidium-to-yeast conversion in the fungus Paracoccidioides brasiliensis.","volume":"56","author":"Salazar","year":"1988","journal-title":"Infect Immun"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R48","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/clinids\/27.5.1138","article-title":"The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992\u20131993: results of population-based laboratory active surveillance.","volume":"27","author":"Rees","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3201\/eid2301.161198","article-title":"Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002\u20132012.","volume":"23","author":"Strollo","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/cid\/ciw808","article-title":"Socioeconomic factors explain racial disparities in invasive community-associated methicillin-resistant Staphylococcus aureus disease rates.","volume":"64","author":"See","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R51","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJMsa012979","article-title":"Contribution of major diseases to disparities in mortality.","volume":"347","author":"Wong","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R52","unstructured":"Fanfair RN. Blacks at twofold increased risk for candidemia infections. Infectious Disease News, Science Daily. Rockville, MD; 2011. https:\/\/www.healio.com\/infectious-disease\/vaccine-preventable-diseases\/news\/print\/infectious-disease-news\/%7Bf5afa7f7-85d7-4be9-9700-d02625b9c821%7D\/blacks-at-twofold-increased-risk-for-candidemia-infections"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R53","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/myc.12349","article-title":"Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.","volume":"58","author":"Alp","year":"2015","journal-title":"Mycoses"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R54","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/clind\/15.3.414","article-title":"Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.","volume":"15","author":"Fraser","year":"1992","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R55","doi-asserted-by":"publisher","first-page":"e97596","DOI":"10.1371\/journal.pone.0097596","article-title":"Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.","volume":"9","author":"Lansky","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3201\/eid2404.171807","article-title":"Reemergence of intravenous drug use as risk factor for candidemia, Massachusetts, USA.","volume":"24","author":"Poowanawittayakom","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R57","doi-asserted-by":"publisher","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Trends in emergency department visits for suspected opioid overdoses\u2014United States, July 2016\u2013September 2017.","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016.","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among persons who inject drugs\u2014six sites, 2005\u20132016.","volume":"67","author":"Jackson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R60","unstructured":"CDC. Antibiotic resistance threats in the United States. Washington, DC: US Department of Health and Human Services; 2013. https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/index.html"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R61","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida.","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R62","doi-asserted-by":"publisher","first-page":"ofx175","DOI":"10.1093\/ofid\/ofx175","article-title":"Antifungal susceptibility testing practices at acute care hospitals enrolled in the National Healthcare Safety Network, United States, 2011\u20132015.","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R63","unstructured":"CDC. Lab capacity: Antibiotic Resistance Laboratory Network (AR Lab Network) [Internet]. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/drugresistance\/solutions-initiative\/ar-lab-networks.html"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R64","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","article-title":"Amphotericin B-induced nephrotoxicity: a review.","volume":"12","author":"Fanos","year":"2000","journal-title":"J Chemother"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R66","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S1473-3099(18)30597-8","article-title":"Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey.","volume":"18","author":"Chow","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R67","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses.","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R68","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/JCM.00921-17","article-title":"Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface.","volume":"55","author":"Welsh","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R69","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus\u2014United States, May 2013\u2013August 2016.","volume":"65","author":"Vallabhaneni","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R70","doi-asserted-by":"crossref","first-page":"e00371","DOI":"10.1128\/JCM.00371-18","article-title":"Emerging multidrug-resistant Candida duobushaemulonii infections in Panama hospitals: importance of laboratory surveillance and accurate identification.","volume":"56","author":"Ramos","year":"2018","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.ss6808a1-201909261208-R71","doi-asserted-by":"crossref","first-page":"459","DOI":"10.15585\/mmwr.mm6715a6","article-title":"Notes from the field: surveillance for Candida auris\u2014Colombia, September 2016\u2013May 2017.","volume":"67","author":"Escand\u00f3n","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Surveillance Summaries"],"original-title":[],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T11:58:48Z","timestamp":1611403128000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/68\/ss\/ss6808a1.htm?s_cid=ss6808a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":71,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,9,27]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.ss6808a1","relation":{},"ISSN":["1546-0738","1545-8636"],"issn-type":[{"value":"1546-0738","type":"print"},{"value":"1545-8636","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9,27]]},"published":{"date-parts":[[2019,9,27]]}}}